Guide Therapeutics, Inc.

New Filing
CIK: 0001769132·Other Technology·DELAWARE·Filed: Feb 28, 2019
Total Offering

$5,000,000

Amount Sold

$2,500,000

Investors

1

First Sale

Feb 15, 2019

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
Thomas Reese Saylor
Related Person
James Dahlman
Related Person
Andrew Perlman
Related Person

Company

Guide Therapeutics, Inc.

380 NORTHYARDS BLVD.

ATLANTA, GA, 30313

404-937-3801

SEC Filing

0001769132-19-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Guide Therapeutics, Inc. Form D Filing — $5,000,000 | FilingFlow